 Connection
Ronald Sokol to Cholangitis, Sclerosing
This is a "connection" page, showing publications Ronald Sokol has written about Cholangitis, Sclerosing.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.148 |
|
|
|
-
Shearn CT, Anderson AL, Miller CG, Noyd RC, Devereaux MW, Balasubramaniyan N, Orlicky DJ, Schmidt EE, Sokol RJ. Thioredoxin reductase 1 regulates hepatic inflammation and macrophage activation during acute cholestatic liver injury. Hepatol Commun. 2023 01 01; 7(1):e0020.
Score: 0.714
-
Mack CL, Miethke AG, Hawthorne K, Henn L, Horslen S, Alonso EM, Gupta NA, Sundaram SS, Kohli R, Bozic M, Deneau M, Guthery S, Loomes KM, Valentino PL, Tessier MEM, Shneider B, Magee JC, Karpen S, Rosenthal P, Wang K, Ricciuto A, Sokol RJ, Kamath BM. The Childhood Liver Disease Research Network's prospective characterization of pediatric primary sclerosing cholangitis. Hepatol Commun. 2026 Oct 01; 10(10).
Score: 0.231
-
Shearn CT, Anderson AL, Devereaux MW, Koch SD, Larsen LD, Spencer LA, Orlicky DJ, Colgan SP, Steiner CA, Sokol RJ. Overexpression of TNFa in TNF?ARE+/- mice increases hepatic periportal inflammation and alters bile acid signaling in mice. Hepatol Commun. 2024 12 01; 8(12).
Score: 0.204
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|